̽»¨Ö±²¥

Meet 10 Cambridge spinouts, all hoping to harness the potential of AI for the good of the planet and its people.

Kathryn Chapman, Executive Director of Innovate Cambridge, on the secrets of successful innovation and her ambitious plans for innovation in Cambridge and beyond.Ìý

A team from across the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK government’s new research funding agency.

Cambridge scientists have grown ‘mini-guts’ in the lab to help understand Crohn’s disease, showing that ‘switches’ that modify DNA in gut cells play an important role in the disease and how it presents in patients.

̽»¨Ö±²¥facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.

Connect: Health Tech, the ̽»¨Ö±²¥ of Cambridge Enterprise Zone, has today launched a roadmap, ‘Creating a ̽»¨Ö±²¥ Enterprise Zone for Cambridge across the life and physical sciences’, that examines the challenges faced in futureproofing and sustaining the growth of the life sciences cluster to maintain Cambridge as a global centre of excellence for health tech.

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials.

Three companies,ÌýAstex Pharmaceuticals,ÌýEisai LtdÌýandÌýEli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.

A new collaboration between the ̽»¨Ö±²¥ of Cambridge, Papworth Hospital NHS Foundation Trust and Sunway Medical Centre in Malaysia will see researchers and clinicians from the two countries working together across borders and disciplinary divides to tackle some of the world’s major health challenges.

Ìý